Search

Your search keyword '"Durcan L."' showing total 165 results

Search Constraints

Start Over You searched for: Author "Durcan L." Remove constraint Author: "Durcan L."
165 results on '"Durcan L."'

Search Results

5. Development of baseline stability in an electromagnetic flowmeter for dielectric liquids

7. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry

14. Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial

16. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

17. Genome-wide association study of germline variants and breast cancer-specific mortality

18. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

19. Genome-wide association study of germline variants and breast cancer-specific mortality

20. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

21. Genome-wide association study of germline variants and breast cancer-specific mortality.

22. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

23. Genome-wide association study of germline variants and breast cancer-specific mortality

24. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

25. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

26. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

30. Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

32. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

39. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

40. Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

42. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

43. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

45. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

46. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

50. A novel tumour-based test to identify breast cancer due to BRCA1 and BRCA2 mutations

Catalog

Books, media, physical & digital resources